About Patheon
Patheon is a company based in Durham (United States) founded in 1974 by Doug Sprague was acquired by Thermo Fisher Scientific in August 2017. Patheon has raised $141 million across 4 funding rounds from investors including Thermo Fisher Scientific, Ministry of Economy, Finance and Industrial and Digital Sovereignty and Advent Morro Equity Partners. Patheon has completed 2 acquisitions, including Banner Life Sciences and IRIX Pharmaceuticals. Patheon operates in a competitive market with competitors including LakePharma, Maravai Life Sciences, Grand River Aseptic Manufacturing, AeroSafe Global and Berkshire Sterile Manufacturing, among others.
- Headquarter Durham, United States
- Founders Doug Sprague
- Stage Public
-
Sectors
HealthcareTransportation, Automotive & Logistics
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$141 M (USD)
in 4 rounds
-
Latest Funding Round
$903.72 K (USD), Grant
Dec 20, 2021
-
Investors
Thermo Fisher Scientific
& 3 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Banner Life Sciences
& 1 more
-
Acquired by
Thermo Fisher Scientific
(Aug 29, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Patheon
Unlock access to complete
Unlock access to complete
Software Development Team
330 people
Leadership Team
169 people
Sales and Marketing
138 people
Human Resources and Administration
102 people
Product Management Team
68 people
Finance and Accounting
67 people
Senior Team
59 people
Operations Team
52 people
Unlock access to complete
Funding Insights of Patheon
Patheon has successfully raised a total of $141M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $903.72 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $903,720
-
First Round
First Round
(01 Mar 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Grant - Patheon | Valuation |
investors |
|
| Apr, 2010 | Amount | Post-IPO - Patheon | Valuation |
investors |
|
| Apr, 2007 | Amount | Private Equity Round - Patheon | Valuation |
investors |
Investors in Patheon
Patheon has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, Ministry of Economy, Finance and Industrial and Digital Sovereignty and Advent Morro Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage companies are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
JLL Partners is engaged in middle-market business transformation and investment.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Patheon
Patheon has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Banner Life Sciences and IRIX Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Difficult-to-manufacture APIs and complex intermediates are developed by IRIX Pharmaceuticals.
|
1996 | ||||
|
Fully integrated product development using its formulation technologies.
|
1994 |
Financial Statements - Patheon
Patheon Comparisons
Competitors of Patheon
Patheon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LakePharma, Maravai Life Sciences, Grand River Aseptic Manufacturing, AeroSafe Global and Berkshire Sterile Manufacturing, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
|
| domain | founded_year | HQ Location |
Sterile parenteral CDMO services for development and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
Cold-chain logistics services are provided to the bio-pharma industry.
|
|
| domain | founded_year | HQ Location |
Provider of sterile filling and lyophilization services for clinical and small scale requirements
|
Frequently Asked Questions about Patheon
Patheon was founded in 1974 and raised its 1st funding round 33 years after it was founded.
Patheon is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Patheon is a funded company, having raised a total of $141M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $3M, raised on Mar 01, 2007.
Patheon provides commercial manufacturing and pharmaceutical development services to the pharmaceutical and biotechnology industries worldwide. Its commercial manufacturing activities relate primarily to prescription and OTC products in solid, semi-solid, liquid, and sterile dosage forms. The company also provides a range of specialised pharmaceutical development capability, including high-potency, sterile, lyophilization, and controlled-release. Patheon delivers products to approximately 120 countries and offers an array of services, including manufacturing, logistics, and packaging of conventional dosage forms, sterile dosage forms, and specialised products. Its contract pharmaceutical development services include pre-formulation, formulation and development of dosage forms; development of analytical methods; manufacture to customer specifications of proposed new drug products during the regulatory drug approval process, including the manufacture of pilot batches; clinical packaging; and scale-up and technology transfer services to validate commercial-scale drug manufacturing processes. Patheon was acquired by JLL Partners, a PE firm in 2013, merged with DSM Pharmaceutical Products in 2014 and went public in July 2016 on the NYSE. The company has a presence in 70 countries and claims to have been engaged in either the development or manufacturing of 25 of the top 100 drugs in the market as of 2016.
Patheon's top competitors include Grand River Aseptic Manufacturing, Maravai Life Sciences and OBiO Technology.
Patheon has made 2 acquisitions, including Banner Life Sciences, and IRIX Pharmaceuticals.
Patheon has 4 investors. Key investors include Thermo Fisher Scientific, Ministry of Economy, Finance and Industrial and Digital Sovereignty, Advent Morro Equity Partners, and JLL Partners.